clinical trials | Market Exclusive

Home Tags Clinical trials

Otonomy Inc (NASDAQ:OTIC): Pivotal Data In Focus

- October 10, 2016 0

Here’s Our RedHill Biopharma Ltd – ADR (NASDAQ:RDHL) Yeliva Phase II...

Roger Hannington - October 7, 2016 0

Here’s What Happened With Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) and Tenax Therapeutics...

- October 6, 2016 0

Two FDA Decisions Still To Come Before The Close Of The...

- September 14, 2016 0

Here’s What The Latest Data Could Mean For Repros Therapeutics Inc...

- September 8, 2016 0

Two Catlaysts To Watch Early September In Biotech: Bioline RX Ltd...

- August 24, 2016 0

Portola Pharmaceuticals Inc (NASDAQ:PTLA): A Misinterpretation Discount?

- August 17, 2016 1

What To Look For In The Upcoming Oncomed Pharmaceuticals Inc (NASDAQ:OMED)...

- August 17, 2016 0

Cynapsus Therapeutics Inc (NASDAQ:CYNA) Is Closing In On A Parkinson’s NDA

- July 19, 2016 0

What Went Wrong With Evoke Pharma Inc (NASDAQ:EVOK)?

- July 18, 2016 0

123...7 Page 2 of 7

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

December 9, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 24, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 18, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: clinical trials

Otonomy Inc (NASDAQ:OTIC): Pivotal Data In Focus

Here’s Our RedHill Biopharma Ltd – ADR (NASDAQ:RDHL) Yeliva Phase II...

Here’s What Happened With Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) and Tenax Therapeutics...

Two FDA Decisions Still To Come Before The Close Of The...

Here’s What The Latest Data Could Mean For Repros Therapeutics Inc...

Two Catlaysts To Watch Early September In Biotech: Bioline RX Ltd...

Portola Pharmaceuticals Inc (NASDAQ:PTLA): A Misinterpretation Discount?

What To Look For In The Upcoming Oncomed Pharmaceuticals Inc (NASDAQ:OMED)...

Cynapsus Therapeutics Inc (NASDAQ:CYNA) Is Closing In On A Parkinson’s NDA

What Went Wrong With Evoke Pharma Inc (NASDAQ:EVOK)?

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY